Approval · Notice of Compliance 23148 · 2020
ELIGARD: Notice of Compliance 23148
Issued January 23, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23148
- Date
- January 23, 2020
- Company
- Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of alternate production and packaging
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ELIGARD | Not yet assigned | — |
Medicinal ingredients
- LEUPROLIDE ACETATE 22.5 MG per SYR
- LEUPROLIDE ACETATE 45 MG per SYR
- LEUPROLIDE ACETATE 30 MG per SYR